Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    21995387 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  Chemotherapy and/or Hormone Therapy With or Without Zoledronate in Treating Women With Stage II or Stage III Breast Cancer
Conditions: Breast Cancer;   Metastatic Cancer
Interventions: Drug: zoledronic acid;   Procedure: adjuvant therapy;   Procedure: neoadjuvant therapy

Indicates status has not been verified in more than two years